搜尋結果
鉅亨速報 - Factset 最新調查:Sarepta Therapeutics Inc(SRPT-US)EPS預估上修至4.57元,預估目標價為 ...
鉅亨網 via Yahoo財經香港· 24 小時前FactSet 最新調查:Sarepta Therapeutics Inc(SRPT-US)EPS預估上修,預估EPS、預估營收、目標價、歷史 ...
Pitch Deck Teardown: Feel Therapeutics' $3.5M seed deck
TechCrunch· 21 小時前Feel Therapeutics is working to make mental health care more science-forward. The company makes wearable ...
Neurona Therapeutics細胞療法獲FDA再生醫學先進療法認定
阿思達克財經網· 2 日前智通財經APP獲悉,Neurona Therapeutics公司日前宣佈,美國FDA已授予該公司主要候選細胞療法NRTX-1001 ...
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more ...
CNBC· 1 日前The decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most ...
MapLight Therapeutics Taps Morgan Stanley, Jefferies for IPO
Bloomberg· 4 日前MapLight Therapeutics has picked Morgan Stanley and Jefferies Financial Group Inc. to lead an ...
Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
CNBC· 21 小時前Shares of the biopharma company surged 30% after the U.S. Food and Drug Administration approved ...
Roche partners with Ascidian Therapeutics to develop gene therapies
Reuters· 4 日前, opens new tab will team up with privately held biotech Ascidian Therapeutics to develop gene ...
減肥筆市場未來十年達1000億美元 諾和諾德、禮來兩家瓜分
鉅亨網 via Yahoo財經香港· 1 日前諸如諾和諾德 (NVO-US) 出品的 Wegovy 和禮來公司 (LLY-US) 生產的 Zepbound 這類減肥藥開拓了一個市 ...
NK 細胞是比 CAR-T 更好的癌症療法?
科技新報 TechNews· 2 日前CAR-T(嵌合抗原受體 T 細胞)療法是免疫療法,2017 年首獲美國 FDA 批准治療血癌,是當時重大突破。此法利用病患自己的免疫細胞,改造放大數量後能攻擊癌細胞 ...
Health Care Roundup: Market Talk
The Wall Street Journal· 1 日前Find insight on Zealand Pharma’s petrelintide shot , Sarepta Therapeutics, EssilorLuxottica, ...